首页> 外文期刊>Journal of experimental therapeutics & oncology >Analysis of volumetric and dosimetric changes in mid treatment CT scan in carcinoma nasopharynx: implications for adaptive radiotherapy
【24h】

Analysis of volumetric and dosimetric changes in mid treatment CT scan in carcinoma nasopharynx: implications for adaptive radiotherapy

机译:鼻咽癌中间治疗CT扫描体积和剂量变化分析:适应放疗的含义

获取原文
获取原文并翻译 | 示例
           

摘要

Carcinoma of nasopharynx is a radiosensitive tumor and therapeutic response during radiation treatment can result in dosimetric variations in the delivered dose to the tumor and critical organs. This study was done to evaluate the volumetric and dosimetric changes seen in tumor tissue and organs at risk in a mid treatment planning scan and its implications for adaptive replanning. Twenty patients of locally advanced carcinoma nasopharynx were evaluated. All patients were started on treatment with a baseline treatment plan on SIB-VMAT. To evaluate volumetric and dosimetric changes during treatment, a mid treatment CT scan (MTS) was taken at the 17th fraction of treatment and compared with the baseline planning CT scan (BS). Adaptive treatment plans were generated on the MTS and further treatment was continued on the adaptive plans. The mean weight loss observed at the 17th fraction of treatment was 3.4 ± 2.6 kg(Mean±S.D). The mean neck diameter at C2 level was 14.19+1.02 and 13.29 ± 1.14 cm in the BS and MTS respectively (p=0.001). The GTV 70 volume showed a 29.16% volume loss. The mean doses received by the right and left parotids were 25.45±0.98 and 24.64±3.8 Gy in the baseline treatment plan and 33.21 ±11.29 (p=0.054) and 31.76±8.44 Gy respectively in the MTS (p=0.016) The mean weight loss showed a statistically significant correlation with increase in the right parotid(p=0.043) and left parotid doses(p=0.024). Weight loss during treatment combined with volume changes in target tissues mandate routine adaptive replanning while treating carcinoma nasopharynx.
机译:鼻咽癌的癌是一种放射敏感性肿瘤和辐射治疗过程中的治疗反应可导致肿瘤和关键器官的递送剂量的剂量变化。完成该研究以评估肿瘤组织和器官在中期治疗计划扫描中的体积和剂量变化及其对适应性重新扫描的影响。评估了20名局部晚期癌鼻咽鼻咽癌。所有患者都开始在SIB-VMAT上用基线处理计划进行处理。为了评估治疗过程中的体积和剂量测量变化,在第17次处理中拍摄中间处理CT扫描(MTS),并与基线计划CT扫描(BS)进行比较。在MTS上产生自适应治疗计划,并继续进行自适应计划。在第17次处理中观察到的平均体重减轻是3.4±2.6千克(平均值±S.D)。 C2水平的平均颈部直径分别为14.19±1.02和13.29±1.14厘米(P = 0.001)。 GTV 70体积显示29.16%的体积损失。基线处理计划中,右侧和左侧腮腺接收的平均剂量为25.45±0.98和24.64±3.8Gy,分别在MTS中分别为33.21±11.29(p = 0.054)和31.76±8.44g(p = 0.016)平均重量损失表现出与右腮腺(P = 0.043)和左侧腮腺剂量增加的统计学上显着的相关性(P = 0.024)。治疗过程中的体积损失联合靶组织的体积变化授权常规复制治疗癌鼻咽癌。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号